Search

for
Search:

Sort by

Research

30-60 / 1000+ results

research Platelet-rich Plasma for the Treatment of Erectile Dysfunction: A Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial

20 citations , April 2023 in “The Journal of Urology”

PRP is safe but not more effective than a placebo for treating mild to moderate erectile dysfunction.

A Randomized, Placebo- and Active-Controlled, Parallel-Group, Multicenter, Investigator-Blinded Study of Four Treatment Regimens of Posaconazole in Adults with Toenail Onychomycosis

research A randomized, placebo- and active-controlled, parallel-group, multicenter, investigator-blinded study of four treatment regimens of posaconazole in adults with toenail onychomycosis

February 2010 in “Journal of The American Academy of Dermatology”

Posaconazole is a promising new treatment for toenail fungus.

research Effectiveness of Platelet-Rich Plasma in the Treatment of Androgenic Alopecia Compared to Placebo and Topical Minoxidil: A Systematic Review

December 2022 in “Scientia Pharmaceutica”

PRP is more effective than minoxidil and placebo for treating hair loss.

research Latanoprost and minoxidil: Comparative double-blind, placebo-controlled study for the treatment of hair loss

January 2018 in “Surgical and Cosmetic Dermatology”

Latanoprost and minoxidil effectively control hair loss and increase hair count.

research A randomized, placebo-controlled trial of 1% topical minoxidil solution in the treatment of androgenetic alopecia in Japanese women.

10 citations , May 2007 in “PubMed”

1% topical minoxidil solution significantly improved hair growth in Japanese women with androgenetic alopecia, with no major side effects.

research A Double Blind Randomized Placebo Controlled Clinical Trial of Finasteride in the Treatment of Androgenetic Alopecia

2 citations , January 2002 in “The Chinese Journal of Clinical Pharmacology”

Finasteride effectively improves hair growth in men with minimal side effects.

A Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects with Androgenetic Alopecia

research A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia

97 citations , January 2014 in “Journal of The American Academy of Dermatology”

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

research Platelet-rich Plasma for Androgenetic Alopecia Treatment: A Randomized Placebo-controlled Pilot Study

8 citations , January 2020 in “Acta dermato-venereologica”

PRP injections did not significantly improve hair growth.

Treatment of Androgenetic Alopecia with 5-Aminolevulinic Acid Photodynamic Therapy: A Randomized, Placebo-Controlled, Split-Scalp Study of Efficacy and Safety

research Treatment of androgenetic alopecia with 5-aminolevulinic acid photodynamic therapy: A randomized, placebo-controlled, split-scalp study of efficacy and safety

2 citations , August 2021 in “Photodiagnosis and Photodynamic Therapy”

Using 5-aminolevulinic acid photodynamic therapy for hair loss didn't increase hair growth but slightly reduced scalp oiliness, and it was safe with mild side effects.

research Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.

February 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

Dutasteride 0.5mg is more effective than finasteride 1mg for treating male pattern baldness.

research Evaluation of the effectiveness of androgenetic alopecia treatment in men us- ing platelet-rich plasma: A systematic review of randomized, placebo-con- trolled trials

April 2022

PRP treatment significantly increases hair density in men with androgenetic alopecia.

research Efficacy and safety of tofacitinib in the treatment of adults with lichen planopilaris: A randomized placebo-controlled trial

3 citations , July 2025 in “International Immunopharmacology”

research A new combination of molecules for the treatment of androgenetic alopecia and telogen effluvium: a double-blind randomized, monocentric, placebo-controlled study

1 citations , January 2022 in “Italian journal of dermatology and venereology”

The combination of arginine and zinc reduces hair loss and increases hair growth effectively.

research Turpentine Ointment for the Treatment of Folliculitis: An Open, Prospective, Randomized, Placebo- and Comparator-Controlled Multicenter Trial

4 citations , January 2023 in “Skin Pharmacology and Physiology”

Turpentine ointment is effective and safe for treating folliculitis.

Supplementary Material for: Turpentine Ointment for the Treatment of Folliculitis – An Open, Prospective, Randomized, Placebo- and Comparator-Controlled Multicenter Trial

research Supplementary Material for: Turpentine ointment for the treatment of folliculitis – an open, prospective, randomized, placebo- and comparator-controlled multicenter trial

January 2024 in “Figshare”

Turpentine ointment is an effective and safe treatment for folliculitis.

research Topical Cyperus rotundus essential oil for treatment of axillary hyperpigmentation: a randomized, double‐blind, active‐ and placebo‐controlled study

2 citations , October 2021 in “Clinical and experimental dermatology”

Cyperus rotundus essential oil effectively treats underarm darkening, reduces inflammation, and slows hair growth.

The Importance of Dual 5α-Reductase Inhibition in the Treatment of Male Pattern Hair Loss: Results of a Randomized Placebo-Controlled Study of Dutasteride Versus Finasteride

research The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride

215 citations , November 2006 in “Journal of The American Academy of Dermatology”

Dutasteride more effective for hair growth, but has more side effects than finasteride.

research Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled study

40 citations , January 2013 in “Clinical Cosmetic and Investigational Dermatology”

Desonide is more effective than niacinamide for reducing underarm darkening.

research Faculty Opinions recommendation of Sublingual minoxidil for the treatment of male and female pattern hair loss: a randomized, double-blind, placebo-controlled, phase 1B clinical trial.

September 2021 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

research Faculty Opinions recommendation of Randomized Placebo-Controlled, Double-Blind, Half-Head Study to Assess the Efficacy of Platelet-Rich Plasma on the Treatment of Androgenetic Alopecia.

May 2016 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-Alpha-Reductase in the Treatment of Androgenetic Alopecia

research A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-α-Reductase in the Treatment of Androgenetic Alopecia

68 citations , April 2002 in “Journal of Alternative and Complementary Medicine”

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

research A Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Effectiveness of Botanically Derived Inhibitors of 5-α-Reductase in the Treatment of Androgenetic Alopecia

65 citations , April 2002 in “Journal of Alternative and Complementary Medicine”

Plant extracts effectively reduce hair loss and increase growth, offering a safe alternative treatment.

Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study

research Platelet-Rich Plasma in Combination With 5% Minoxidil Topical Solution and 1 mg Oral Finasteride for the Treatment of Androgenetic Alopecia: A Randomized Placebo-Controlled, Double-Blind, Half-Head Study

19 citations , May 2017 in “Dermatologic Surgery”

Combining platelet-rich plasma with 5% minoxidil solution improves hair regrowth in androgenetic alopecia patients.

Efficacy and Safety of a Dietary Supplement Containing a Lipid Co-Extract from Serenoa Repens and Pygeum Africanum for the Treatment of Androgenetic Alopecia in Women: Results of a Randomized, Double-Blind, Placebo-Controlled Clinical Trial

research Efficacy and safety of a dietary supplement containing a lipid co-extract from Serenoa repens and Pygeum africanum for the treatment of androgenetic alopecia (AGA) in women. Results of a randomized, double-blind, placebo-controlled clinical trial

2 citations , April 2016 in “Más dermatología”

The supplement with Serenoa repens and Pygeum africanum significantly increased active hair growth and decreased rest phase hair in post-menopausal women with hair loss, with only mild digestive side effects.

Faculty Opinions Recommendation of a Randomized, Active- and Placebo-Controlled Study of the Efficacy and Safety of Different Doses of Dutasteride Versus Placebo and Finasteride in the Treatment of Male Subjects With Androgenetic Alopecia

research Faculty Opinions recommendation of A randomized, active- and placebo-controlled study of the efficacy and safety of different doses of dutasteride versus placebo and finasteride in the treatment of male subjects with androgenetic alopecia.

March 2014 in “Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature”

Dutasteride 0.5mg was found to be more effective than finasteride 1mg in treating male pattern hair loss, with similar side effects.

research 42134 Long-term Efficacy of Guselkumab (GUS) on Fatigue and Identification of Early Treatment Targets: Post Hoc Analysis Through 2 Years of a Phase 3, Randomized, Double-blind, Placebo-controlled Study in Biologic-naïve Patients With Psoriatic Arthritis (PsA)

September 2023 in “Journal of the American Academy of Dermatology”

Guselkumab effectively reduces fatigue in Psoriatic Arthritis patients over two years.

A Multicenter, Randomized, Placebo-Controlled, Double-Blind Clinical Trial of a Novel Formulation of 5% Minoxidil Topical Foam Versus Placebo in the Treatment of Androgenetic Alopecia in Men

research A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men

142 citations , August 2007 in “Journal of The American Academy of Dermatology”

New 5% minoxidil foam effectively promotes hair growth and is safe for use.

research Comparison of Spironolactone, Flutamide, and Finasteride Efficacy in the Treatment of Hirsutism: A Randomized, Double Blind, Placebo-Controlled Trial

46 citations , January 2000 in “The Journal of Clinical Endocrinology and Metabolism”

research Evaluating the efficacy of low‑level laser‑based treatments for androgenetic alopecia: A network meta‑analysis

August 2025 in “Arabixiv (OSF Preprints)”

Low-level laser therapy effectively improves hair growth in androgenetic alopecia with minimal side effects.

Efficacy of Platelet-Rich Plasma Injection for the Treatment of Male Androgenetic Alopecia: A Systematic Review and Meta-Analysis of Changes in Hair Density

research Efficacy of Platelet-Rich Plasma Injection for The Treatment of Male Androgenetic Alopecia – A Systematic Review and Meta-Analysis of Changes in Hair Density

January 2022

Platelet-rich plasma injections effectively increase hair density in men suffering from common hair loss.

← Previous page Next page →